Longitudinal gray matter changes in multiple sclerosis-Differential scanner and overall disease-related effects

Human Brain Mapping

Volumn 33, Issue 5, 2012, Pages 1225-1245

  Bendfeldt, Kerstin ^a   Hofstetter, Louis ^a   Kuster, Pascal ^a   Traud, Stefan ^a   Mueller Lenke, Nicole ^a   Naegelin, Yvonne ^a   Kappos, Ludwig ^a   Gass, Achim ^a   Nichols, Thomas E ^b,c   Barkhof, Frederik ^d   Vrenken, Hugo ^d   Roosendaal, Stefan D ^d   Geurts, Jeroen J G ^d   Radue, Ernst Wilhelm ^a   Borgwardt, Stefan J ^a,e  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Gray matter; Longitudinal; MRI; Multiple sclerosis; Scanner; Voxel based morphometry

Indexed keywords

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN REGION; CEREBELLUM; DISEASE DURATION; FEMALE; FRONTAL GYRUS; GRAY MATTER; HEMISPHERE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBITAL CORTEX; PARIETAL LOBE; PRECUNEUS; PRIORITY JOURNAL; UNCUS; VOXEL BASED MORPHOMETRY;

ADULT; CASE-CONTROL STUDIES; CEREBRAL CORTEX; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; TIME FACTORS;

EID: 84859444103     PISSN: 10659471     EISSN: 10970193     Source Type: Journal    
DOI: 10.1002/hbm.21279     Document Type: Article

References (58)

1. Ashburner J, Friston KJ ( 1999): Nonlinear spatial normalization using basis functions. Hum Brain Mapp 7: 254-266.
2. Ashburner J, Friston KJ ( 2000): Voxel-based morphometry-The methods. NeuroImage 11: 805-821.
3. Audoin B, Davies GR, Finisku L, Chard DT, Thompson AJ, Miller DH ( 2006): Localization of grey matter atrophy in early RRMS. J Neurol 253: 1495-1501.
4. Barkhof F, Calabresi PA, Miller DH, Reingold SC ( 2009): Imaging outcomes for neuroprotection and repair in multiple sclerosis trials. Nat Rev Neurol 5: 256-266.
5. Battaglini M, Giorgio A, Stromillo ML, Bartolozzi ML, Guidi L, Federico A, De Stefano N ( 2009): Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis. J Neurol Sci 282: 55-60.
6. Bendfeldt K, Kuster P, Traud S, Egger H, Winklhofer S, Mueller-Lenke N, Naegelin Y, Gass A, Kappos L, Matthews PM, Nichols, Thomas E, Radue Ernst-Wilhelm, Borgwardt Stefan J. ( 2009): Association of regional gray matter volume loss and progression of white matter lesions in multiple sclerosis-A longitudinal voxel-based morphometry study. NeuroImage 45: 60-67.
7. Bendfeldt K, Blumhagen JO, Egger H, Loetscher P, Denier N, Kuster P, Traud S, Mueller-Lenke N, Naegelin Y, Gass A, Hirsch J, Kappos L, Nichols TE, Radue EW, Borgwardt SJ. ( 2010a): Spatiotemporal distribution pattern of white matter lesion volumes and their association with regional grey matter volume reductions in relapsing-remitting multiple sclerosis. Hum Brain Mapp 31: 1542-1555.
8. Bendfeldt K, Egger H, Nichols TE, Loetscher P, Denier N, Kuster P, Traud S, Mueller-Lenke N, Naegelin Y, Gass A, Kappos L, Radue EW, Borgwardt SJ. ( 2010b): Effect of immunomodulatory medication on regional gray matter loss in relapsing-remitting multiple sclerosis-A longitudinal MRI study. Brain Res 1325: 174-182.
9. Bendfeldt K, Kappos L, Radue EW, Borgwardt S ( 2010c): Longitudinal spatiotemporal distribution of gray and white matter pathology in multiple sclerosis. AJNR Am J Neuroradiol 31: E45; author reply E46.
10. Bodini B, Khaleeli Z, Cercignani MH, Miller D, Thompson AJ, Ciccarelli O ( 2009): Exploring the relationship between white matter and gray matter damage in early primary progressive multiple sclerosis: An in vivo study with TBSS and VBM. Hum Brain Mapp 30: 2852-2861.
11. Borgwardt SJ, McGuire PK, Aston J, Berger G, Dazzan P, Gschwandtner U, Pfluger M, D'Souza M, Radue EW, Riecher-Rossler A ( 2007a): Structural brain abnormalities in individuals with an at-risk mental state who later develop psychosis. Br J Psychiatry Suppl 51: s69-s75.
12. Borgwardt SJ, Riecher-Rossler A, Dazzan P, Chitnis X, Aston J, Drewe M, Gschwandtner U, Haller S, Pfluger M, Rechsteiner E, et al. ( 2007b): Regional gray matter volume abnormalities in the at risk mental state. Biol Psychiatry 61: 1148-1156.
13. Borgwardt SJ, McGuire P, Fusar-Poli P, Radue EW, Riecher-Rossler A ( 2008): Anterior cingulate pathology in the prodromal stage of schizophrenia. Neuroimage 39: 553-554.
14. Briellmann RS, Syngeniotis A, Jackson GD ( 2001): Comparison of hippocampal volumetry at 1.5 tesla and at 3 tesla. Epilepsia 42: 1021-1024.
15. Ceccarelli A, Rocca MA, Pagani E, Colombo B, Martinelli V, Comi G, Filippi M ( 2008): A voxel-based morphometry study of grey matter loss in MS patients with different clinical phenotypes. NeuroImage 42: 315-322.
16. Chard DT, Griffin CM, Parker GJM, Kapoor R, Thompson AJ, Miller DH ( 2002): Brain atrophy in clinically early relapsing-remitting multiple sclerosis. Brain 125: 327-337.
17. Charil A, Dagher A, Lerch JP, Zijdenbos AP, Worsley KJ, Evans AC ( 2007): Focal cortical atrophy in multiple sclerosis: Relation to lesion load and disability. NeuroImage 34: 509-517.
18. Chen JT, Narayanan S, Collins DL, Smith SM, Matthews PM, Arnold DL ( 2004): Relating neocortical pathology to disability progression in multiple sclerosis using MRI. NeuroImage 23: 1168-1175.
19. Clark KA, Woods RP, Rottenberg DA, Toga AW, Mazziotta JC ( 2006): Impact of acquisition protocols and processing streams on tissue segmentation of T1 weighted MR images. NeuroImage 29: 185-202.
20. Dalton CM, Chard DT, Davies GR, Miszkiel KA, Altmann DR, Fernando K, Plant GT, Thompson AJ, Miller DH ( 2004): Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. Brain 127: 1101-1107.
21. De Stefano N, Matthews PM, Filippi M, Agosta F, De Luca M, Bartolozzi ML, Guidi L, Ghezzi A, Montanari E, Cifelli A, et al. ( 2003): Evidence of early cortical atrophy in MS: Relevance to white matter changes and disability. Neurology 60: 1157-1162.
22. Derakhshan M, Caramanos Z, Giacomini PS, Narayanan S, Maranzano J, Francis SJ, Arnold DL, Collins DL ( 2010): Evaluation of automated techniques for the quantification of grey matter atrophy in patients with multiple sclerosis. NeuroImage 52: 1261-1267.
23. Ewers M, Teipel SJ, Dietrich O, Schönberg SO, Jessen F, Heun R, Scheltens P, Pol Lvd, Freymann NR, Moeller HJ, et al. ( 2006): Multicenter assessment of reliability of cranial MRI. Neurobiol Aging 27: 1051-1059.
24. Fusar-Poli P, Perez J, Broome M, Borgwardt S, Placentino A, Caverzasi E, Cortesi M, Veggiotti P, Politi P, Barale F, et al. ( 2007): Neurofunctional correlates of vulnerability to psychosis: A systematic review and meta-analysis. Neurosci Biobehav Rev 31: 465-484.
25. Giorgio A, Palace J, Johansen-Berg H, Smith SM, Ropele S, Fuchs S, Wallner-Blazek M, Enzinger C, Fazekas F ( 2010): Relationships of brain white matter microstructure with clinical and MR measures in relapsing-remitting multiple sclerosis. J Magn Reson Imaging 31: 309-316.
26. Good CD, Johnsrude IS, Ashburner J, Henson RNA, Friston KJ, Frackowiak RSJ ( 2001): A voxel-based morphometric study of ageing in 465 normal adult human brains. NeuroImage 14: 21-36.
27. Han X, Jovicich J, Salat D, van der Kouwe A, Quinn B, Czanner S, Busa E, Pacheco J, Albert M, Killiany R, et al. ( 2006): Reliability of MRI-derived measurements of human cerebral cortical thickness: The effects of field strength, scanner upgrade and manufacturer. Neuroimage 32: 180-194.
28. Hayasaka S, Phan KL, Liberzon I, Worsley KJ, Nichols TE ( 2004): Nonstationary cluster-size inference with random field and permutation methods. NeuroImage 22: 676-687.
29. Huppertz HJ, Kroll-Seger J, Kloppel S, Ganz RE, Kassubek J ( 2010): Intra- and interscanner variability of automated voxel-based volumetry based on a 3D probabilistic atlas of human cerebral structures. NeuroImage 49: 2216-2224.
30. Jasperse B, Vrenken H, Sanz-Arigita E, de Groot V, Smith SM, Polman CH, Barkhof F ( 2007): Regional brain atrophy development is related to specific aspects of clinical dysfunction in multiple sclerosis. NeuroImage 38: 529-537.
31. Jovicich J, Czanner S, Greve D, Haley E, van der Kouwe A, Gollub R, Kennedy D, Schmitt F, Brown G, MacFall J, et al. ( 2006): Reliability in multi-site structural MRI studies: Effects of gradient non-linearity correction on phantom and human data. NeuroImage 30: 436-443.
32. Kappos L, Antel J, Comi G, Montalban X, O'Connor P, Polman CH, Haas T, Korn AA, Karlsson G, Radue EW, et al. ( 2006): Oral fingolimod (FTY720) for relapsing multiple sclerosis. N Engl J Med 355: 1124-1140.
33. Kutzelnigg A, Lassmann H ( 2005): Cortical lesions and brain atrophy in MS. J Neurol Sci 233: 55-59.
34. Li X, Li L, Lu H, Liang Z ( 2005): Partial volume segmentation of brain magnetic resonance images based on maximum a posteriori probability. Med Phys 32: 2337-2345.
35. Mikol DD, Barkhof F, Chang P, Coyle PK, Jeffery DR, Schwid SR, Stubinski B, Uitdehaag BMJ ( 2008): Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs. Glatiramer acetate in relapsing MS disease [REGARD] study): A multicentre, randomized, parallel, open-label trial. Lancet Neurol 7: 903-914.
36. Moorhead TWJ, Job DE, Spencer MD, Whalley HC, Johnstone EC, Lawrie SM ( 2005): Empirical comparison of maximal voxel and non-isotropic adjusted cluster extent results in a voxel-based morphometry study of comorbid learning disability with schizophrenia. NeuroImage 28: 544-552.
37. Moorhead TWJ, Gountouna VE, Job DE, McIntosh AM, Romaniuk L, Lymer GK, Whalley HC, Waiter GD, Brennan D, Ahearn TS, et al. ( 2009): Prospective multi-centre voxel based morphometry study employing scanner specific segmentations: Procedure development using CaliBrain structural MRI data. BMC Med Imaging 9: 8.
38. Nakamura K, Fisher E ( 2009): Segmentation of brain magnetic resonance images for measurement of gray matter atrophy in multiple sclerosis patients. NeuroImage 44: 769-776.
39. O'Connor P, Filippi M, Arnason B, Comi G, Cook S, Goodin D, Hartung H-P, Jeffery D, Kappos L, Boateng F, et al. ( 2009): 250 μg or 500 μg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: A prospective, randomized, multicentre study. Lancet Neurol 8: 889-897.
40. Pagani E, Rocca MA, Gallo A, Rovaris M, Martinelli V, Comi G, Filippi M ( 2005): Regional brain atrophy evolves differently in patients with multiple sclerosis according to clinical phenotype. AJNR Am J Neuroradiol 26: 341-346.
41. Pardoe H, Pell GS, Abbott DF, Berg AT, Jackson GD ( 2008): Multi-site voxel-based morphometry: Methods and a feasibility demonstration with childhood absence epilepsy. NeuroImage 42: 611-616.
42. Pirko I, Lucchinetti CF, Sriram S, Bakshi R ( 2007): Gray matter involvement in multiple sclerosis. Neurology 68: 634-642.
43. Polman CH, Reingold SC, Edan G, Filippi M, Hartung H-P, Kappos L, Lublin F, Metz L, McFarland H, O'Connor P, et al. ( 2005): Diagnostic criteria for multiple sclerosis: 2005 revisions to the ldquoMcDonald Criteriardquo. Ann Neurol 58: 840-846.
44. Preboske GM, Gunter JL, Ward CP, Jack CRJr ( 2006): Common MRI acquisition non-idealities significantly impact the output of the boundary shift integral method of measuring brain atrophy on serial MRI. Neuroimage 30: 1196-1202.
45. Prinster A, Quarantelli M, Orefice G, Lanzillo R, Brunetti A, Mollica C, Salvatore E, Morra VB, Coppola G, Vacca G, et al. ( 2006): Grey matter loss in relapsing-remitting multiple sclerosis: A voxel-based morphometry study. NeuroImage 29: 859-867.
46. Quarantelli M, Ciarmiello A, Morra VB, Orefice G, Larobina M, Lanzillo R, Schiavone V, Salvatore E, Alfano B, Brunetti A ( 2003): Brain tissue volume changes in relapsing-remitting multiple sclerosis: Correlation with lesion load. NeuroImage 18: 360-366.
47. Raz N, Lindenberger U, Rodrigue KM, Kennedy KM, Head D, Williamson A, Dahle C, Gerstorf D, Acker JD ( 2005): Regional brain changes in aging healthy adults: General trends, individual differences and modifiers. Cereb Cortex 15: 1676-1689.
48. Sailer M, Fischl B, Salat D, Tempelmann C, Schonfeld MA, Busa E, Bodammer N, Heinze H-J, Dale A ( 2003): Focal thinning of the cerebral cortex in multiple sclerosis. Brain 126: 1734-1744.
49. Schmahmann JD, Doyon J, McDonald D, Holmes C, Lavoie K, Hurwitz AS, Kabani N, Toga A, Evans A, Petrides M ( 1999): Three-dimensional MRI atlas of the human cerebellum in proportional stereotaxic space. NeuroImage 10: 233-260.
50. Schnack HG, van Haren NE, Brouwer RM, van Baal GC, Picchioni M, Weisbrod M, Sauer H, Cannon TD, Huttunen M, Lepage C, et al. ( 2010): Mapping reliability in multicenter MRI: Voxel-based morphometry and cortical thickness. Hum Brain Mapp 31: 1967-1982.
51. Schwemer G ( 2000): General linear models for multicenter clinical trials. Control Clin Trials 21: 21-29.
52. Sepulcre J, Sastre-Garriga J, Cercignani M, Ingle GT, Miller DH, Thompson AJ ( 2006): Regional gray matter atrophy in early primary progressive multiple sclerosis: A voxel-based morphometry study. Arch Neurol 63: 1175-1180.
53. Sowell ER, Peterson BS, Kan E, Woods RP, Yoshii J, Bansal R, Xu D, Zhu H, Thompson PM, Toga AW ( 2007): Sex differences in cortical thickness mapped in 176 healthy individuals between 7 and 87 years of age. Cereb Cortex 17: 1550-1560.
54. Stonnington CM, Tan G, Klöppel S, Chu C, Draganski B, Jack CR Jr, Chen K, Ashburner J, Frackowiak RSJ ( 2008): Interpreting scan data acquired from multiple scanners: A study with Alzheimer's disease. NeuroImage 39: 1180-1185.
55. Tardif CL, Collins DL, Pike GB ( 2010): Regional impact of field strength on voxel-based morphometry results. Hum Brain Mapp 31: 943-957.
56. Tedeschi G, Lavorgna L, Russo P, Prinster A, Dinacci D, Savettieri G, Quattrone A, Livrea P, Messina C, Reggio A, et al. ( 2005): Brain atrophy and lesion load in a large population of patients with multiple sclerosis. Neurology 65: 280-285.
57. Tiberio M, Chard DT, Altmann DR, Davies G, Griffin CM, Rashid W, Sastre-Garriga J, Thompson AJ, Miller DH ( 2005): Gray and white matter volume changes in early RRMS: A 2-year longitudinal study. Neurology 64: 1001-1007.
58. White T, O'Leary D, Magnotta V, Arndt S, Flaum M, Andreasen NC ( 2001): Anatomic and functional variability: The effects of filter size in group fMRI data analysis. NeuroImage 13: 577-588.